BerkeleyNguyenLimketkaiMDPhD
Gastroenterology • Los Angeles, CAInflammatory Bowel Disease, Nutrition
Associate Clinical Professor, UCLA School of Medicine
Dr. Limketkai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 UCLA Medical Plaza Suite 345
Los Angeles, CA 90095Phone+1 310-206-6279Fax+1 310-206-0275
Education & Training
Johns Hopkins UniversityPhD, Clinical Investigation, 2011 - 2017
Johns Hopkins UniversityFellowship, Gastroenterology, 2010 - 2014- Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
University of Cincinnati College of MedicineClass of 2007
Certifications & Licensure
CA State Medical License 2014 - 2026
MD State Medical License 2011 - 2014- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis Start of enrollment: 2014 Dec 01
- Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections Start of enrollment: 2016 Aug 01
- Gastric Acid Suppression and Probiotic Colonization Start of enrollment: 2018 Mar 20
Publications & Presentations
PubMed
- 34 citationsUS Practice Patterns and Impact of Monitoring for Mucosal Inflammation After Biologic Initiation in Inflammatory Bowel Disease.Berkeley N. Limketkai, Siddharth Singh, Vipul Jairath, William J. Sandborn, Parambir S. Dulai
Inflammatory Bowel Diseases. 2019-10-18 - 226 citationsACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.Colleen R. Kelly, Monika Fischer, Jessica R. Allegretti, Kerry L. LaPlante, David B. Stewart
The American Journal of Gastroenterology. 2021-06-01 - 22 citationsUstekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis.Gala M Godoy Brewer, George Salem, Muhammad A Afzal, Berkeley N Limketkai, Zadid Haq
BMJ Open Gastroenterology. 2021-12-01
Authored Content
- Q&A: Avoidant/Restrictive Food Intake Disorder in Crohn’s Disease and Ulcerative ColitisMay 2024
- Mo1705 STABLE POLYPECTOMY COMPLICATION RATES IN AN ERA OF INCREASING USE OF ENDOSCOPIC MUCOSAL RESECTION (EMR)May 2018
- Mo1705 STABLE POLYPECTOMY COMPLICATION RATES IN AN ERA OF INCREASING USE OF ENDOSCOPIC MUCOSAL RESECTION (EMR)May 2018
Press Mentions
Inflammatory Bowel Disease: How Oxygen Chambers, Apple Watches May Improve TreatmentJanuary 19th, 2023- 4 Ways Machine Learning Is Fixing to Finetune Clinical NutritionJune 16th, 2021
Endoscopy Given IBD Patients Within 6 Months of Starting Biologic May Limit Complications, Study SaysNovember 8th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
